HEMATOLOGY TRANSFUSION AND CELL THERAPY

eISSN: 2531-1379pISSN: 2531-1379

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

SJR
Q4Hematology

Journal Specifications

Overview
  • Publisher
    ELSEVIER
  • Language
    English
  • Frequency
    Quarterly
General Details
Publication Details
  • Publication ID scheme
    DOI
View less

Topics Covered

Seborrheic keratosis
Surgical patients
Ferritin
Anemia
Hematopoietic stem cell transplantation
Cold Agglutinin
Questionnaire
Thrombotic thrombocytopenic purpura
Prognostic score
Preoperative anemia
Inventory management
Acute leukemia
Systematic review
Daratumumab
Mean platelet volume
Induction therapy
Acute chest syndrome
Clinical case
Cohort study
Hemophagocytic lymphohistiocytosis

Recently Published Papers

Year-wise Publication

FAQs

Since when has HEMATOLOGY TRANSFUSION AND CELL THERAPY been publishing? Faqs

The HEMATOLOGY TRANSFUSION AND CELL THERAPY has been publishing since 2018 till date.

How frequently is the HEMATOLOGY TRANSFUSION AND CELL THERAPY published? Faqs

HEMATOLOGY TRANSFUSION AND CELL THERAPY is published Quarterly.

Who is the publisher of HEMATOLOGY TRANSFUSION AND CELL THERAPY? Faqs

The publisher of HEMATOLOGY TRANSFUSION AND CELL THERAPY is ELSEVIER.

How can I view the journal metrics of HEMATOLOGY TRANSFUSION AND CELL THERAPY on editage? Faqs

For the HEMATOLOGY TRANSFUSION AND CELL THERAPY metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of HEMATOLOGY TRANSFUSION AND CELL THERAPY? Faqs

The eISSN number is 2531-1379 and pISSN number is 2531-1379 for HEMATOLOGY TRANSFUSION AND CELL THERAPY.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Seborrheic keratosis, Surgical patients, Ferritin, Anemia, Hematopoietic stem cell transplantation, Cold Agglutinin, Questionnaire, Thrombotic thrombocytopenic purpura, Prognostic score, Preoperative anemia, Inventory management, Acute leukemia, Systematic review, Daratumumab, Mean platelet volume, Induction therapy, Acute chest syndrome, Clinical case, Cohort study, Hemophagocytic lymphohistiocytosis.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.